As RBC reports with reference to the information from the Pharmkonadzor 2.0 database, no information has been received about the development of reactions associated with nonspecific motor disorders, including falls, for drugs based on this active ingredient.
According to Sergei Babak, professor of the Department of Phthisiology and Pulmonology of the Medical Faculty of the Moscow State Medical University, side effects are extremely rare when using the recommended dose of the drug.
Earlier, Izvestia reported that products based on favipiravir can cause side effects, such as night walking and fast running syndromes, as well as an increased risk of falls.